CADTH has received a submission from Actavis Speciality Pharmaceuticals for Constella (linaclotide) for patients with irritable bowel syndrome (IBS) with constipation. CATH is calling on patients in Canada with IBS to provide input into its asssessment of the submission.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/388